Successful treatment by double-filtration plasmapheresis of a patient with bullous pemphigoid: Effects in vivo on transcripts of several genes for chemokines and cytokines in peripheral blood mononuclear cells

British Journal of Dermatology

Volumn 148, Issue 3, 2003, Pages 573-579

  Hatano, Yutaka ^a   Katagiri, K ^a   Arakawa, S ^a   Umeki, T ^a   Takayasu, S ^a   Fujiwara, S ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Bullous pemphigoid; Chemokine; Cytokine; Mononuclear cell; Plasmapheresis

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; PREDNISOLONE; RANTES; VIDARABINE;

ARTICLE; BLOOD CELL; BLOOD FILTRATION; CASE REPORT; CELL ISOLATION; CLINICAL FEATURE; CONTROLLED STUDY; DOUBLE FILTRATION PLASMAPHERESIS; FEMALE; GENETIC TRANSCRIPTION; GLUCOSE INTOLERANCE; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; LIVER DYSFUNCTION; MONONUCLEAR CELL; OSTEOPOROSIS; PATIENT; PEMPHIGOID; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

CHEMOKINES; CYTOKINES; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; INTERFERONS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MACROPHAGE INFLAMMATORY PROTEINS; MIDDLE AGED; PEMPHIGOID, BULLOUS; PLASMAPHERESIS; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037362495     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05233.x     Document Type: Article

References (30)

1. Yamada H, Yaguchi H, Takamori K, Ogawa H. Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid. Ther Apheresis 1997; 1: 178-82.
2. D'Auria L, Fei PC, Ameglio F. Cytokines and bullous pemphigoid. Eur Cytokine Netw 1999; 10: 123-33.
3. Katagiri K, Itami S, Hatano Y, Takayasu S. Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). Clin Exp Immunol 1997; 108: 289-94.
4. Katagiri K, Itami S, Hatano Y, Takayasu S. In vivo expression of IL-4, IL-5, IL-13, and IFN-γ mRNA in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura's disease. Br J Dermatol 1997; 137: 972-7.
5. Hatano Y, Katagiri K, Takayasu S. Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1α (MIP-1α), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clin Exp Immunol 1999; 117: 237-43.
6. Cohen LM, Skopicki DK, Harrist TJ, Clark WH Jr. Bullous pemphigoid. In: Lever's Histopathology of the Skin (Elder D. Elenitsas R. Jaworsky C, Johnson B Jr. eds). 8th edn. Philadelphia: Lippincott-Raven. 1997: 226-8.
7. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
8. Wojnarowska F. Bullous pemphigoid. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA, Breathnach SM, eds). 6th edn, Vol. 3. Oxford: Blackwell Science Ltd. 1998: 1866-73.
9. Paludan SR. Synergistic action of pro-inflammatory agents: cellular and molecular aspects. J Leukoc Biol 2000; 67: 18-25.
10. Alam R. Chemokines in allergic inflammation. J Allergy Clin Immunol 1997; 99: 273-7.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
12. De Pita O, Frezzolini A, Cianchini G et al. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30). Arch Dermatol Res 1997; 299: 667-70.
13. Büdinger L, Borradori L, Yee C et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998; 102: 2082-9.
14. Rico MJ, Benning C, Weingart ES et al. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br J Dermatol 1999; 140: 1079-86.
15. Eming R, Büdinger L, Riechers R et al. Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay. Br J Dermatol 2000; 143: 1279-82.
16. Lin MS, Fu CL, Giudice GJ et al. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol 2000; 115: 955-61.
17. Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol 2000; 122: 91-100.
18. H1-dominant type after varicella-zoster virus infection in atopic dermatitis. J Allergy Clin Immunol 1997; 100: 274-82.
19. D'Auria L, Pietravalle M, Mastroianni A et al. IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid; correlations with eosinophil cationic protein. RANTES, IgE and disease severity. Arch Dermatol Res 1998; 290: 25-7.
20. Sun CC, Wu J, Wong TT et al. High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T-cell activities. Br J Dermatol 2000; 143; 1235-40.
21. Marsh CB, Gadek JE, Kindt GC et al. Monocyte Fcγ receptor cross-linking induces IL-8 production. J Immunol 1995; 155: 3161-7.
22. Foreback JL, Remick DG, Crockett-Torabi E, Ward PA. Cytokine responses of human blood monocytes stimulated with Igs. Inflammation 1997; 21: 501-17.
23. Gosset P, Tillie-Leblond I, Oudin S et al. Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophage activated by IgE receptors. J Allergy Clin Immunol 1999; 103: 289-97.
24. Katoh N. Hirano S, Yasuno H. A role of IgE in the pathogenesis of atopic dermatitis. Clin Immunol 2000; 33: 420-5. (in Japanese).
25. Katoh N, Bieber T. FcεRI mediates production of proinflammatory cytokines by human monocytes and monocyte-derived dendritic cells. J Invest Dermatol 1998; 110: 647.
26. Fauci AS, Dale DC. Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976; 84: 304-15.
27. Haddy TB, Rana SR. Leukocyte response to administration of corticosteroid in healthy black children with neutropenia. J Pediatr 1994; 124: 739-41.
28. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-62.
29. Kitagawa S. Adrenocorticosteroid-induced neutrophilia. Ryoikibetsu Shokogun Shirizu 1998; 21: 21-2 (in Japanese).
30. Tesar V, Jelinkova E, Masek Z et al. Influence of plasma exchange on serum levels of cytokines and adhesion molecules in ANCA-positive renal vasculitis. Blood Purif 1998; 16: 72-80.